Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch in Canada in November
Business Wire•28/10/2026•08:00 ET
0
Key Highlights
- ➤Dexcom G7 15 Day launches in Canada next month for adults 18 and older
- ➤Public reimbursement begins in November for many eligible Canadians with diabetes
- ➤Private plans covering CGMs will add Dexcom G7 15 Day coverage in November
- ➤Dexcom G7 15 Day offers up to 15.5 days of wear
- ➤Dexcom G7 15 Day reports overall MARD of 8.0%
Expert Statements
André Côté, Vice President and General Manager, Dexcom Canada
“For people living with diabetes, staying aware of their glucose is part of everyday life. Our goal is to make that experience simple, seamless and intuitive.”
André Côté, Vice President and General Manager, Dexcom Canada
“With Dexcom G7 15 Day, we’re delivering the longest-lasting(1) sensor on the market that does not compromise on accuracy and performance. We are also focusing on launching with significant public and private reimbursement already in place, helping more Canadians benefit from this technology right away.”
Malcolm Kelly, Dexcom Warrior
“Living with type 2 diabetes means there is always something to think about, whether it’s checking my glucose levels or making decisions about my health.”
Malcolm Kelly, Dexcom Warrior
“Having a CGM that lasts longer means one less thing to manage and fewer interruptions to my routine. Those small changes can make a big difference when you’re living with diabetes.”
Dexcom G7 15 Day Continuous Glucose Monitoring System to Launch in Canada in November
* The longest-lasting and most accurate(1) continuous glucose monitoring (CGM) system authorized by Health Canada will offer people living with diabetes over the age of 18 up to 15.5 days of wear with fewer sensor changes.(2)
Get started
Create a free account to read the full story.